LLY compared with SPRB: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

SPRBSpruce Biosciences, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

SPRBSpruce Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,417.89▲+0.60%· post 1,420.50· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

SPRBSpruce Biosciences, Inc.

44.90▲+4.88%· post 44.90· delayed

After hoursNov 4 '26delayed

Mkt cap$123.0MRevenue$697,000Q4 FY24Revenue$5MFY24

Compare

After hoursNov 4 '26delayed

LLYELI Lilly & Co

SPRBSpruce Biosciences, Inc.

1,417.89▲+0.60%post 1,420.50delayed

Price

44.90▲+4.88%post 44.90delayed

$1.3T

Mkt cap

$123.0M

Q3 FY26$24.4B

Revenue

$697,000Q4 FY24

FY25$65.2B

Revenue

$5MFY24

LLY1,417.89▲+0.60%vsSPRB44.90▲+4.88%After hoursNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SPRB: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only SPRB 3

LLYEli Lillysupplier

BMRNBioMarin Pharmaceuticalsupplier

—HBM Alpha Therapeuticsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

LLY, solidSPRB, dashed